Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 336

1.
4.

B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and classical Burkitt's lymphoma: A case report and review.

Chettiankandy TJ, Tupkari JV, Kumar K, Ahire MS.

J Oral Maxillofac Pathol. 2016 May-Aug;20(2):333. doi: 10.4103/0973-029X.185936.

5.

Epstein-Barr virus (EBV) positive diffuse large B cell lymphoma of the elderly-experience of a single center from Turkey.

Ozsan N, Cagirgan S, Saydam G, Gunes A, Hekimgil M.

Pathol Res Pract. 2013 Aug;209(8):471-8. doi: 10.1016/j.prp.2013.04.014. Epub 2013 May 9.

PMID:
23726928
6.

Pathologic and clinical features of 77 Hodgkin's lymphoma patients treated in a lymphoma protocol (LNH87): a GELA study.

Cazals-Hatem D, André M, Mounier N, Copin MC, Divine M, Berger F, Bosly A, Kerneis Y, Brière J, Quesnel B, Diebold J, Gaulard P.

Am J Surg Pathol. 2001 Mar;25(3):297-306.

PMID:
11224599
7.

[Mediastinal large B-cell lymphoma. A retrospective anatomic-clinical study of 26 cases].

Tchen N, Eghbali H, Soubeyran P, Trojani M, Richaud P, Bonnel C, Quénel-Tueux N, Hoerni B.

Bull Cancer. 1997 Jul;84(7):704-8. French.

8.

T-cell/histiocyte-rich large B-cell lymphoma is a disseminated aggressive neoplasm: differential diagnosis from Hodgkin's lymphoma.

Fraga M, Sánchez-Verde L, Forteza J, García-Rivero A, Piris MA.

Histopathology. 2002 Sep;41(3):216-29.

PMID:
12207783
9.

New insights into the biology of molecular subtypes of diffuse large B-cell lymphoma and Burkitt lymphoma.

Frick M, Dörken B, Lenz G.

Best Pract Res Clin Haematol. 2012 Mar;25(1):3-12. doi: 10.1016/j.beha.2012.01.003. Epub 2012 Feb 8. Review.

PMID:
22409819
10.

Gray zone lymphomas in pediatric patients.

Liang X, Greffe B, Cook B, Giller R, Graham DK, McGranahan AN, Wang M.

Pediatr Dev Pathol. 2011 Jan-Feb;14(1):57-63. doi: 10.2350/09-10-0724-CR.1. Epub 2010 Mar 23.

PMID:
20331368
11.

Gray zone lymphoma: chromosomal aberrations with immunophenotypic and clinical correlations.

Eberle FC, Salaverria I, Steidl C, Summers TA Jr, Pittaluga S, Neriah SB, Rodriguez-Canales J, Xi L, Ylaya K, Liewehr D, Dunleavy K, Wilson WH, Hewitt SM, Raffeld M, Gascoyne RD, Siebert R, Jaffe ES.

Mod Pathol. 2011 Dec;24(12):1586-97. doi: 10.1038/modpathol.2011.116. Epub 2011 Aug 5.

12.

Gray zone lymphoma: better treated like hodgkin lymphoma or mediastinal large B-cell lymphoma?

Dunleavy K, Grant C, Eberle FC, Pittaluga S, Jaffe ES, Wilson WH.

Curr Hematol Malig Rep. 2012 Sep;7(3):241-7. doi: 10.1007/s11899-012-0130-5. Review.

PMID:
22833351
13.

Prognostic value of MYC rearrangement in cases of B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma.

Lin P, Dickason TJ, Fayad LE, Lennon PA, Hu P, Garcia M, Routbort MJ, Miranda R, Wang X, Qiao W, Medeiros LJ.

Cancer. 2012 Mar 15;118(6):1566-73. doi: 10.1002/cncr.26433. Epub 2011 Aug 31.

14.

Large B-cell lymphoma with Hodgkin's features.

García JF, Mollejo M, Fraga M, Forteza J, Muniesa JA, Pérez-Guillermo M, Pérez-Seoane C, Rivera T, Ortega P, Piris MA.

Histopathology. 2005 Jul;47(1):101-10.

PMID:
15982329
15.

Mediastinal lymphomas: primary mediastinal (thymic) large B-cell lymphoma versus classical Hodgkin lymphoma, histopathologic dilemma solved?

Pervez S, Khawaja RD.

Pathol Res Pract. 2010 Jun 15;206(6):365-7. doi: 10.1016/j.prp.2010.01.003. Epub 2010 Feb 24.

PMID:
20185248
16.

B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma: report of a case in the oral cavity.

Jaradat JM, Potluri A, Bilodeau EA.

Indian J Dent Res. 2013 May-Jun;24(3):384-6. doi: 10.4103/0970-9290.118016.

17.

T-cell leukemia 1 expression in nodal Epstein-Barr virus-negative diffuse large B-cell lymphoma and primary mediastinal B-cell lymphoma.

Gualco G, Weiss LM, Barber GN, Bacchi CE.

Hum Pathol. 2010 Sep;41(9):1238-44. doi: 10.1016/j.humpath.2010.01.015. Epub 2010 Apr 10.

PMID:
20382409
18.

Prognostic impact of p53 aberrations for R-CHOP-treated patients with diffuse large B-cell lymphoma.

Stefancikova L, Moulis M, Fabian P, Vasova I, Zedek F, Ravcukova B, Muzik J, Kuglik P, Vranova V, Falkova I, Hrabalkova R, Smardova J.

Int J Oncol. 2011 Dec;39(6):1413-20. doi: 10.3892/ijo.2011.1170. Epub 2011 Aug 18.

PMID:
21874232
19.

Expression of Grb2 distinguishes classical Hodgkin lymphomas from primary mediastinal B-cell lymphomas and other diffuse large B-cell lymphomas.

Miles RR, Mankey CC, Seiler CE 3rd, Smith LB, Teruya-Feldstein J, Hsi ED, Elenitoba-Johnson KS, Lim MS.

Hum Pathol. 2009 Dec;40(12):1731-7. doi: 10.1016/j.humpath.2009.05.009. Epub 2009 Aug 27.

PMID:
19716163
20.

Primary mediastinal large B-cell lymphoma. A clinicopathologic study of 141 cases compared with 916 nonmediastinal large B-cell lymphomas, a GELA ("Groupe d'Etude des Lymphomes de l'Adulte") study.

Cazals-Hatem D, Lepage E, Brice P, Ferrant A, d'Agay MF, Baumelou E, Brière J, Blanc M, Gaulard P, Biron P, Schlaifer D, Diebold J, Audouin J.

Am J Surg Pathol. 1996 Jul;20(7):877-88.

PMID:
8669537

Supplemental Content

Support Center